Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1408-1415

  Loram, Lisa C ^a   Taylor, Frederick R ^a   Strand, Keith A ^a   Frank, Matthew G ^a   Sholar, Paige ^a   Harrison, Jacqueline A ^a   Maier, Steven F ^a   Watkins, Linda R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokines; Intrathecal; Mechanical allodynia; TLR4

Indexed keywords

CD14 ANTIGEN; CORTICOSTERONE; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EXPOSURE; IMMUNOCOMPETENT CELL; MALE; MYELITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; CORTICOSTERONE; GLUCOCORTICOIDS; HYPERALGESIA; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; NEUROGLIA; PAIN MEASUREMENT; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 80052393941     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.04.013     Document Type: Article

References (44)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Alexander J.K., DeVries A.C., Kigerl K.A., Dahlman J.M., Popovich P.G. Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation. Brain Behav. Immun. 2009, 23:851-860.
4. Arruda J.L., Sweitzer S., Rutkowski M.D., DeLeo J.A. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res. 2000, 879:216-225.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Caso J.R., Lizasoain I., Lorenzo P., Moro M.A., Leza J.C. The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats. Neuroscience 2006, 142:59-69.
7. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009, 32:1-32.
8. De Leo J.A., Tawfik V.L., LaCroix-Fralish M.L. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122:17-21.
9. DeLeo J.A., Colburn R.W., Nichols M., Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 1996, 16:695-700.
10. Elliott J.M., Noteboom J.T., Flynn T.W., Sterling M. Characterization of acute and chronic whiplash-associated disorders. J. Orthop. Sports Phys. Ther. 2009, 39:312-323.
11. Fan J., Frey R.S., Malik A.B. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 2003, 112:1234-1243.
12. Fleshner M., Deak T., Spencer R.L., Laudenslager M.L., Watkins L.R., Maier S.F. A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology 1995, 136:5336-5342.
13. Frank M.G., Miguel Z.D., Watkins L.R., Maier S.F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. Coli lipopolysaccharide. Brain Behav. Immun. 2010, 24:19-30.
14. Grau J.W., Washburn S.N., Hook M.A., Ferguson A.R., Crown E.D., Garcia G., Bolding K.A., Miranda R.C. Uncontrollable stimulation undermines recovery after spinal cord injury. J. Neurotrauma 2004, 21:1795-1817.
15. Hains L.E., Loram L.C., Weiseler J.L., Frank M.G., Bloss E.B., Sholar P., Taylor F.R., Harrison J.A., Martin T.J., Eisenach J.C., Maier S.F., Watkins L.R. Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming. J. Pain 2010, 11:1004-1014.
16. Harvey L.O. Efficient estimation of sensory thresholds. Behav. Res. Methods Instrum. Comput. 1986, 18:623-632.
17. Hutchinson M.R., Zhang Y., Brown K., Coats B.D., Shridhar M., Sholar P.W., Patel S.J., Crysdale N.Y., Harrison J.A., Maier S.F., Rice K.C., Watkins L.R. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. NeuroSci. 2008, 28:20-29.
18. Johnson J.D., O'Connor K.A., Deak T., Stark M., Watkins L.R., Maier S.F. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun. 2002, 16:461-476.
19. Johnson J.D., O'Connor K.A., Hansen M.K., Watkins L.R., Maier S.F. Effects of prior stress on LPS-induced cytokine and sickness responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R422-R432.
20. Johnson J.D., O'Connor K.A., Watkins L.R., Maier S.F. The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004, 127:569-577.
21. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
22. Khasar S.G., Burkham J., Dina O.A., Brown A.S., Bogen O., Alessandri-Haber N., Green P.G., Reichling D.B., Levine J.D. Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J. Neurosci. 2008, 28:5721-5730.
23. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 2007, 282:14975-14983.
24. Loram L.C., Harrison J.A., Sloane E.M., Hutchinson M.R., Sholar P., Taylor F.R., Berkelhammer D., Coats B.D., Poole S., Milligan E.D., Maier S.F., Rieger J., Watkins L.R. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. J. Neurosci. 2009, 29:14015-14025.
25. Loram L.C., Harrison J.A., Chao L., Taylor F.R., Reddy A., Travis C.L., Giffard R., Al-Abed Y., Tracey K., Maier S.F., Watkins L.R. Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats. Brain Behav. Immun. 2010, 24:959-967.
26. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000, 861:105-116.
27. Milligan E.D., Langer S.J., Sloane E.M., He L., Wieseler-Frank J., O'Connor K., Martin D., Forsayeth J.R., Maier S.F., Johnson K., Chavez R.A., Leinwand L.A., Watkins L.R. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur. J. NeuroSci. 2005, 21:2136-2148.
28. Munhoz C.D., Lepsch L.B., Kawamoto E.M., Malta M.B., Lima Lde S., Avellar M.C., Sapolsky R.M., Scavone C. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J. Neurosci. 2006, 26:3813-3820.
29. Nilsen K.B., Sand T., Westgaard R.H., Stovner L.J., White L.R., Bang Leistad R., Helde G., Ro M. Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients. Eur. J. Pain 2007, 11:743-755.
30. O'Connor K.A., Johnson J.D., Hansen M.K., Wieseler Frank J.L., Maksimova E., Watkins L.R., Maier S.F. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003, 991:123-132.
31. O'Connor K.A., Ginsberg A.B., Maksimova E., Wieseler Frank J.L., Johnson J.D., Spencer R.L., Campeau S., Watkins L.R., Maier S.F. Stress-induced sensitization of the hypothalamic-pituitary adrenal axis is associated with alterations of hypothalamic and pituitary gene expression. Neuroendocrinology 2004, 80:252-263.
32. Rezai-Zadeh K., Gate D., Town T. CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?. J. Neuroimmune Pharmacol. 2009, 4:462-475.
33. Romero-Sandoval E.A., Horvath R.J., DeLeo J.A. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr. Opin. Investig. Drugs 2008, 9:726-734.
34. Saito O., Svensson C.I., Buczynski M.W., Wegner K., Hua X.Y., Codeluppi S., Schaloske R.H., Deems R.A., Dennis E.A., Yaksh T.L. Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br. J. Pharmacol. 2010, 160:1754-1764.
35. Somers T.J., Keefe F.J., Godiwala N., Hoyler G.H. Psychosocial factors and the pain experience of osteoarthritis patients: new findings and new directions. Curr. Opin. Rheumatol. 2009, 21:501-506.
36. Sorrells S.F., Caso J.R., Munhoz C.D., Sapolsky R.M. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009, 64:33-39.
37. Takasaki I., Kurihara T., Saegusa H., Zong S., Tanabe T. Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. Eur. J. Pharmacol. 2005, 524:80-83.
38. Wang S., Lim G., Zeng Q., Sung B., Ai Y., Guo G., Yang L., Mao J. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J. Neurosci. 2004, 24:8595-8605.
39. Watkins L.R., Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2003, 2:973-985.
40. Watkins L.R., Milligan E.D., Maier S.F. Spinal cord glia: new players in pain. Pain 2001, 93:201-205.
41. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., Maier S.F. Norman cousins lecture. Glia as the " bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav. Immun. 2007, 21:131-146.
42. Watkins L.R., Hutchinson M.R., Rice K.C., Maier S.F. The " toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 2009, 30:581-591.
43. Yeager M.P., Rassias A.J., Pioli P.A., Beach M.L., Wardwell K., Collins J.E., Lee H.K., Guyre P.M. Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin. Crit. Care Med. 2009, 37:2727-2732.
44. Zautra A.J., Parrish B.P., Van Puymbroeck C.M., Tennen H., Davis M.C., Reich J.W., Irwin M. Depression history, stress, and pain in rheumatoid arthritis patients. J. Behav. Med. 2007, 30:187-197.